BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND ARNT, HIF1BETA, 405, ENSG00000143437, P27540, HIF-1beta, HIF1B, TANGO AND Prognosis
28 results:

  • 1. Genetic and epigenetic prognosticators of neuroendocrine tumours of the GI tract, liver, biliary tract and pancreas: A systematic review and meta-analysis.
    Mestre-Alagarda C; Srirajaskanthan R; Zen Y; Giwa M; Howard M; Ooft ML
    Histopathology; 2024 Jan; 84(2):255-265. PubMed ID: 37565289
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. "Time" for obesity-related cancer: The role of the circadian rhythm in cancer pathogenesis and treatment.
    Miro C; Docimo A; Barrea L; Verde L; Cernea S; Sojat AS; Marina LV; Docimo G; Colao A; Dentice M; Muscogiuri G
    Semin Cancer Biol; 2023 Jun; 91():99-109. PubMed ID: 36893964
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Parathyroid carcinoma: Report of 10 patients and literature review.
    Miao XY; Wang XL; Lyu ZH; Ba JM; Pei Y; Dou JT; Gu WJ; Du J; Guo QH; Chen K; Mu YM
    Neuro Endocrinol Lett; 2022 Nov; 43(4):233-238. PubMed ID: 36528886
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. HIF-1α and Caspase-3 expression in aggressive papillary thyroid carcinoma.
    Zhang L; Shi B; Hu M; Qian L
    World J Surg Oncol; 2022 Nov; 20(1):353. PubMed ID: 36329448
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Biological behavior of familial papillary thyroid microcarcinoma: Spanish multicenter study.
    Ríos A; Rodríguez MA; Puñal JA; Moreno P; Mercader E; Ferrero E; Ruiz-Pardo J; Morlán MA; Martín J; Durán-Poveda M; Bravo JM; Casanova D; Egea MPS; Torregrosa NM; Exposito-Rodríguez A; Martínez-Fernández G; Carrión AM; Vidal O; Herrera F; Ruiz-Merino G; Rodríguez JM
    Langenbecks Arch Surg; 2022 Dec; 407(8):3631-3642. PubMed ID: 36251077
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Prognostic predictors in recurrent adult granulosa cell tumors of the ovary: a systematic review and meta-analysis.
    Inzani F; Santoro A; Travaglino A; D'Alessandris N; Raffone A; Straccia P; Angelico G; Arciuolo D; Scaglione G; Valente M; Tralongo P; Gallotta V; Zannoni GF
    Arch Gynecol Obstet; 2022 Aug; 306(2):315-321. PubMed ID: 34799743
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Pre-operative radiomics model for prognostication in resectable pancreatic adenocarcinoma with external validation.
    Healy GM; Salinas-Miranda E; Jain R; Dong X; Deniffel D; Borgida A; Hosni A; Ryan DT; Njeze N; McGuire A; Conlon KC; Dodd JD; Ryan ER; Grant RC; Gallinger S; Haider MA
    Eur Radiol; 2022 Apr; 32(4):2492-2505. PubMed ID: 34757450
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Determination of Potential Therapeutic Targets and Prognostic Markers of Ovarian cancer by Bioinformatics Analysis.
    Zhang J; Huang S; Quan L; Meng Q; Wang H; Wang J; Chen J
    Biomed Res Int; 2021; 2021():8883800. PubMed ID: 33829065
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Association of Performance Status With Survival in Patients With Advanced Non-Small Cell Lung cancer Treated With Pembrolizumab Monotherapy.
    Sehgal K; Gill RR; Widick P; Bindal P; McDonald DC; Shea M; Rangachari D; Costa DB
    JAMA Netw Open; 2021 Feb; 4(2):e2037120. PubMed ID: 33570575
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Risk Factors of Metastatic Lymph Nodes in Papillary Thyroid Microcarcinoma.
    Ruiz Pardo J; Ríos A; Rodríguez JM; Paredes M; Soriano V; Oviedo MI; Hernández AM; Parrilla P
    Cir Esp (Engl Ed); 2020 Apr; 98(4):219-225. PubMed ID: 31980154
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Carcinoembryonic antigen levels correlated with advanced disease in medullary thyroid cancer.
    Turkdogan S; Forest VI; Hier MP; Tamilia M; Florea A; Payne RJ
    J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):55. PubMed ID: 30223887
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Predicting Response to Standard First-line Treatment in High-grade Serous Ovarian Carcinoma by Angiogenesis-related Genes.
    Mendiola M; Redondo A; Heredia-Soto V; Herranz J; Berjón A; Hernández A; Miguel-Martín M; Crespo R; Barriuso J; Cruz P; Yébenes L; Peláez-García A; Castelo B; DE Molina AR; Feliu J; Hardisson D
    Anticancer Res; 2018 Sep; 38(9):5393-5400. PubMed ID: 30194194
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic cancer and Validate Their Prognostic Significance with the cancer Genome Atlas Data.
    Zhang Z; Pan B; Lv S; Ji Z; Wu Q; Lang R; He Q; Zhao X
    Cell Physiol Biochem; 2018; 49(2):678-695. PubMed ID: 30165365
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Impact of ovarian metastases on survival in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancy originating from appendiceal and colorectal cancer.
    Bignell MB; Mehta AM; Alves S; Chandrakumaran K; Dayal SP; Mohamed F; Cecil TD; Moran BJ
    Colorectal Dis; 2018 Aug; 20(8):704-710. PubMed ID: 29502336
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Therapeutic lateral neck dissection in well-differentiated thyroid cancer: Analysis on factors predicting distribution of positive nodes and prognosis.
    Lombardi D; Paderno A; Giordano D; Barbieri D; Taboni S; Piazza C; Cappelli C; Bertagna F; Barbieri V; Piana S; Bellafiore S; Spriano G; Mercante G; Nicolai P
    Head Neck; 2018 Feb; 40(2):242-250. PubMed ID: 28963802
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Vascular Endothelial Growth Factor (VEGF) Polymorphisms and Serum VEGF Levels in Women With Epithelial Ovarian cancer, Benign Tumors, and Healthy Ovaries.
    González-Palomares B; Coronado Martín PJ; Maestro de Las Casas ML; Veganzones de Castro S; Rafael Fernández S; Vidaurreta Lázaro M; De la Orden García V; Vidart Aragon JA
    Int J Gynecol Cancer; 2017 Jul; 27(6):1088-1095. PubMed ID: 28574932
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Stage IV Gastro-Entero-Pancreatic Neuroendocrine Neoplasms: A Risk Score to Predict Clinical Outcome.
    Panzuto F; Merola E; Pavel ME; Rinke A; Kump P; Partelli S; Rinzivillo M; Rodriguez-Laval V; Pape UF; Lipp R; Gress T; Wiedenmann B; Falconi M; Delle Fave G
    Oncologist; 2017 Apr; 22(4):409-415. PubMed ID: 28232598
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Overexpression of homeobox B-13 correlates with angiogenesis, aberrant expression of EMT markers, aggressive characteristics and poor prognosis in pancreatic carcinoma.
    Zhai LL; Wu Y; Cai CY; Tang ZG
    Int J Clin Exp Pathol; 2015; 8(6):6919-27. PubMed ID: 26261579
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Sub-Classification of Lateral Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma by Pathologic Criteria.
    Jeon MJ; Kim WG; Jang EK; Choi YM; Song DE; Sung TY; Yoon JH; Chung KW; Hong SJ; Ryu JS; Han JM; Kim TY; Shong YK; Kim WB
    PLoS One; 2015; 10(7):e0133625. PubMed ID: 26186205
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Prognostic determinants of adrenocortical carcinoma in adults].
    Zhang MF; Wang C; Huang H; Ding ZY; Liu Y; Deng H; Li SQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Mar; 46(2):248-52. PubMed ID: 25924439
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.